: EQT AB buys Baring Private Equity Asia to grows its global reach
Swedish private equity firm agrees to pay 6.8 billion euros ($7.5 billion) to boost its presence in Asia in a deal that will lift its...
Bond Report: Treasury yields stabilize at almost 3-year highs ahead of Fed’s policy decision
2-, 10- and 30-year Treasury yields held at nearly 3-year highs ahead of a Federal Reserve decision that's expected to deliver a quarter-point rate hike.
Market Snapshot: Dow industrials surge more than 400 points with investors focused on Fed’s first interest-rate hike in 4 years
U.S. stocks climb on Wednesday, extending the previous session's rally, as traders await a monetary-policy decision from the U.S. Federal Reserve.
Truist cuts Disney price target by 20% to $160 as it incorporates Russia exit and DTC to model
Truist Securities lowered its stock price target for Walt Disney Co. a full 20% to $160 from $200 on Wednesday after updating its model to...
Verizon wins $966.5 million in Department of Defense business
Verizon Communications Inc. said Wednesday that the U.S. Department of Defense has awarded its public-sector unit three task-order awards worth $966.5 million. Verizon will be...
Moderna says Japanese government has ordered additional 70 million doses of its COVID booster vaccine
Moderna Inc. said Wednesday the Japanese government has ordered an additional 70 million doses of its COVID-19 booster vaccine or an updated booster vaccine candidate,...
Biogen’s stock gains after sharing longer term data for its Alzheimer’s disease drug
Shares of Biogen Inc. gained 4.3% in premarket trading on Wednesday after the company announced new data for its Alzheimer's disease drug demonstrating reductions in...
Raymond James: Small-cap biotechs on track for ‘worst 12-month run’ in decades
Small-cap biotechnology companies are on track for the worst 12 months in more than 15 years when compared with their large-cap biotech peers, according to...
Apellis shares jump 6% after the company announces new data for its geographic atrophy drug
Shares of Apellis Pharmaceuticals Inc. gained 6.1% in premarket trading on Wednesday after the company shared longer-term clinical data demonstrating that intravitreal pegcetacoplan reduced geographic...